Friday after hours
Dublin, Ohio-based home builder Dominion Homes Inc. (Nasdaq: DHOM) reported after the close Friday a doubling of its first-quarter net loss – to $11.5 million, or $1.41 per diluted share, compared with a net loss of $5.1 million, or $0.63 per diluted share last year. For the quarter ended March 31, revenue also plunged – to $33.8 million, from the delivery of 165 homes, compared with revenue of $61.8 million, or the delivery of 315 homes, in the prior year period. The company’s stock closed today down $0.40, or 6.7%, to $5.60. One analyst polled by Thomson First Call had estimated a net loss of $0.86 per share.
Shares of Quovadx Inc. (Nasdaq: QVDX) continued to edge higher in extended-hours trading Friday after the firm announced first-quarter results. Shares were up $0.05, or 1.6%, to $3.15 after having closed up 4% at $3.10. The Greenwood Village, Colo.-based software company said it swung to a net profit of $12.8 million, or $0.30 per share, on revenue of $13.5 million, compared with a net loss of $7.8 million, or $0.19 per share, in the year-ago period. The results from the latest period included a gain of $15.4 million, or $0.37 a share, from the sale of CareSciene. Earlier in the day, Quovadx said its pending acquisition by Battery Ventures had been amended to include a purchase price of $139.1 million, or $3.20 a share, up from the $136.7 million, or $3.15 a share, offered last month.
Mannatech Inc.’s (Nasdaq: MTEX) stock climbed by $0.56, or 3.9%, to $15 in after-hours trading after the company reported record first-quarter earnings. For the three months ended March 31, the Coppell, Tx.-based nutritional supplement developer said it earned net income of $6.9 million, or $0.26 per diluted share, on revenue of $104.8 million, compared with net income of $5.9 million, or $0.22, on revenue of $99 million, in the 2006 first quarter. During the quarter, the firm launched its “Optimal Skin Care System” in the United States and Canada.
Shares of Ann Arbor, Mich.-based Advanced Photonix Inc. (AMEX: API) dipped by $0.015, or 0.93%, to $1.60 in after-hours trading today when the firm announced it had received two contracts from the Department of Defense totaling $200,000. Each contract is a Phase I feasibility project. If awarded, the contracted amounts could range up to a maximum of $750,000 per project, with a maximum funding duration of two years. The company will own the rights to any developed technology and is free to commercialize it in both private and/or military markets.
Odyssey HealthCare Inc.’s (Nasdaq: ODSY) stock rose $0.70, or 5.5%, to $13.40 late today after the Dallas-based hospice care provider announced plans to buy back $50 million of its outstanding shares of common stock over the next 12 months. Based on the May 3, 2007, closing price of $12.36, approximately 4.0 million shares, or 12% of the company's shares outstanding, could be repurchased for $50 million. The repurchased shares will be added to the treasury shares of the company and may be used for employee stock plans and for other corporate purposes.
